Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 4/4/2020
SIETES contiene 92956 citas

 
 
 1 a 20 de 31 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Law SWY, Wong AYS, Anand S, Wong ICK, Chan EW. Neurospychiatric events associated with leukotriene-modifying agents: a systematic review. Drug Saf 2018;41:marzo. [Ref.ID 102559]
2. Cita con resumen
Laidlaw TM, Boyce JA. Aspirin-exacerbated respiratory disease — New prime suspects. N Engl J Med 2016;374:484-8. [Ref.ID 99993]
3. Cita con resumen
Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence?. Drug Saf 2011;34:533-44. [Ref.ID 90892]
5. Cita con resumen
Fanta CH. Asthma. N Engl J Med 2009;360:1002-14. [Ref.ID 85400]
6.
Watkins PB, Dube LM, Walton-Bowen K, Cameron CM, Kasten LE. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma. Drug Saf 2007;30:805-15. [Ref.ID 81132]
7.
Snyder L, Blanc PD, Katz PP, Yelin EH, Eisner MD. Leukotriene modifier use and asthma severity. Arch Intern Med 2004;164:617-22. [Ref.ID 69620]
8.
Carty E, Rampton D S. Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol 2003;56:351-61. [Ref.ID 67632]
9.
García-Marcos L, Schuster A, Pérez-Yarza E G. Benefit-risk assessment of antileukotriens in the management of asthma. Drug Saf 2003;26:483-518. [Ref.ID 66445]
10.
Naureckas E T, Solway J. Mild asthma. N Engl J Med 2001;345:1257-62. [Ref.ID 59024]
11. Cita con resumen
Anónimo. Drugs for asthma. Med Lett Drugs Ther 2000;42:19-24. [Ref.ID 49862]
12.
Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet 2000;38:271-90. [Ref.ID 49676]
13. Cita con resumen
Anónimo. Pimozide - warning concerning sudden deaths. WHO Pharmaceuticals Newsletter 1999;9-10:3. [Ref.ID 49596]
14.
Anónimo. New drug interaction warnings! Sudden deaths reported with pimozide (Orap). Worst Pills Best Pills 1999;5:87. [Ref.ID 48301]
15.
Anónimo. The long overdue withdrawal of the dangerous antihistamine astemizole (HISMANAL) from the market. Worst Pills Best Pills 1999;5:57-8. [Ref.ID 46188]
16.
Anónimo. Drugs for asthma. Med Lett Drugs Ther 1999;41:5-10. [Ref.ID 43172]
17.
Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197-206. [Ref.ID 42408]
18.
O'Byrne PM, Israel E, Drazen JM. Antileukotrienes in the treatment of asthma. Ann Intern Med 1997;127:472-80. [Ref.ID 34830]
19.
Spector SL. Leukotriene activity modulation in asthma. Drugs 1997;54:369-84. [Ref.ID 33907]
20.
Anónimo. Zileuton for asthma. Med Lett Drugs Ther 1997;39:18-9. [Ref.ID 32793]
Seleccionar todas
 
 1 a 20 de 31 siguiente >>